High-Slice Computed Tomography Scanners Dominate Global Market

The global computed tomography (CT) market is experiencing significant growth, with a valuation of USD 6.3 billion in 2024 and an anticipated expansion to USD 11.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.0% during 2025–2032. This upward trajectory is primarily driven by the increasing applications of CT scanners across various medical procedures, including comprehensive imaging of the brain and body. Technological advancements and substantial government investments in countries such as India, China, and Japan are further propelling market growth.

Key Insights

Technological Advancements

Over the past decade, CT devices have seen significant technological developments, including the emergence of low-dose and automated CT scanners. These innovations offer superior image quality and enhanced spatial resolution with minimal radiation exposure. Notable advancements include iterative reconstruction technology, which provides better images at reduced radiation doses, and spectral imaging that utilizes dual energy sources for improved clarity.

Market Segmentation

·         By Type: High-slice CT scanners dominate the market, accounting for a 40% revenue share in 2024. Their superior diagnostic capabilities, such as producing clearer images with lower radiation doses, make them preferable for complex imaging procedures, including cardiovascular assessments.

·         By Application: The oncology segment leads the market, driven by increased cancer awareness and advancements in detection techniques. CT scans are extensively used to assess metastasis and provide high-clarity images vital for cancer diagnosis, staging, and treatment monitoring.

Regional Trends

·         North America: Holding a 40% revenue share in 2024, North America's dominance is attributed to the presence of key industry players and a high prevalence of chronic diseases. Continuous product innovations and a strong healthcare infrastructure further bolster the market in this region.

·         Asia-Pacific (APAC): APAC is projected to experience the highest CAGR of 8.5% during the forecast period. Factors such as the rising prevalence of cancer and cardiovascular diseases, coupled with growing healthcare investments in countries like China and India, contribute to this rapid growth.

Competitive Landscape

The CT market is fragmented, featuring a mix of established companies and emerging players. Key industry participants include GE HealthCare Technologies Inc., Siemens Healthineers, and Canon Inc., among others. These companies are actively engaging in product launches, strategic collaborations, and technological innovations to maintain a competitive edge.

In summary, the computed tomography market is poised for substantial growth, driven by technological advancements, expanding applications in medical diagnostics, and significant investments in healthcare infrastructure across various regions.

Read More

What Are Factors Affecting Photoacoustic Imaging Industry?

The global photoacoustic imaging market is witnessing growth and is projected to reach USD 279.3 million by 2030. This growth can be ascribed to the increasing count of cancer cases and growing acceptance of progressive treatments throughout the world. The rising healthcare investments and rising elderly populace are some other reasons propelling the need for photoacoustic imaging systems.

The photoacoustic imaging industry is projected to experience quicker development in the software and other accessories category, based on product. This can be credited to the technical improvements that would permit the introduction of new and enhanced components for photoacoustic imaging systems.

For example, multispectral photoacoustic study contrast and application for measurement of photoacoustic imaging agents and the detection of sentinel lymph nodes is possible through software with a digital radio frequency RFMode Mode export capability.

In recent years, pre-clinical bifurcation had a greater share in the industry for photoacoustic imaging, on the basis of application. The industry lead of this category is mainly because of the technical improvements in the field of photoacoustic imaging, armed with the growing requirement for non-invasive imaging methods for small animals that are utilized in pre-clinical studies, and increasing count of steps by public and private establishments to aid pre-clinical research.

In the past few years, the North American region dominated the market with the largest share. This development can be mainly credited to the growing occurrence of chronic illnesses, the increasing elderly populace, and rising healthcare investments.

For Example, as per the United Nations World Population Ageing 2019 statistics, in North America, there were around 59.9 million individuals’ elderly 65 years and more in 2019, and this count is estimated to surge to 80.2 million by 2030. Therefore, the huge aging populace in North America leads to a high requirement for photoacoustic imaging studies, which fuels industry development.

Hence, the increasing count of cancer cases and growing acceptance of progressive treatments throughout the world. The rising healthcare investments and rising elderly populace are some other reasons propelling the need for photoacoustic imaging systems. 

Read More

Medical Device Outsourcing Industry IS Dominated by North America

The medical device outsourcing market had the size of USD 112.1 billion in 2022, and this will reach USD 273.0 billion by 2030, powering at a at a rate of 11.8% by the end of this decade, as per a market research report by P&S Intelligence.

To learn more about this report: https://bit.ly/44mPUyM

Contract manufacturing is a conventional technique for outsourcing medical devices. Though access to inexpensive labor is the reason, producers outsource production, the major factor for contract medical product manufacturing is less time taken for marketing the products.

Furthermore, outsourcing numerous production phases to many partners reduces the total time taken for developing new devices or products.

Regulatory process for the product commercialization has become more intense and rigorous, because of the incessant development of the medical device industry. 

The regulatory compliance outsourcing is becoming popular in the industry since the providers help the manufacturing companies for getting timely launch/approval of their products with numerous other advantages, including reduced cost, more time for the organization’s staff toward core activities, and easy penetration of the market in other nations.

The cardiology category dominates the industry. This is because of the escalating count of CVDs, such as atrial fibrillation, myocardial infarction, angina pectoris, hypertensive heart disease, rheumatic heart disease, and congenital heart disease; and increasing surgical procedures.

Moreover, because of the substantial intricacies of CVD devices, increasing requirement for technical knowhow, and production of these kinds of products might bring about high cost to the OEMs, resulting in the higher rate of outsourcing.

The plastic surgery category will grow the fastest in the future. This has a lot to do with the growing count of minimally invasive aesthetic surgeries and growing number of products for outsourcing. 

Moreover, the obtainability of skilled outsourcing providers adhering to regulatory criteria and the increasing requirement for cosmetic procedures are mainly responsible for the growth of the category.

Contract manufacturing had the largest revenue share in the medical device outsourcing market, of about 30%, in 2022, and will continue to do so in the years to come.

This is because of the increasing requirement for medical components for many applications, growing preference for good and safe equipment for patient care, and mounting necessity for services, for example laser processing, precision grinding, stamping, and milling, insert molding & turning to design a comprehensive device.

North America was the market dominator, with a revenue share of about 40%, and it will maintain its position in the years to come. 

This is because of the wide use of pioneering technology, the existence of numerous medical device manufacturers outsourcing some of their regulatory and consulting purposes to regulatory service providers, growing minimally invasive and noninvasive processes, and the increase in capital spending on healthcare.

It is because of the continuous technological advancements going around the world, the demand for medical device outsourcing is on the rise.

Read More